Anti-CGRP (Calcitonin Gene-Related Peptide) biologics: a new era for migraine prevention

There have not been any major developments over the past years in the field of migraine; the last major advance was the introduction of triptans in the early 1990s. We are now entering a new era for migraine prevention with the development of drugs targeting calcitonin gene-related peptide (CGRP) or its receptor. As part of the Teva Satellite Symposium titled "Optimism and opportunities with an